EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sentinel Lymph Node Mapping in Endometrial Cancer in the Molecular Era: Current Evidence, Clinical Controversies, and Unresolved Questions

Raffaele Tinelli iD, Felice Sorrentino iD, Daniela Surico iD, Alessandro Messina iD, Stefano Angioni, Giorgio Bogani iD, Carmen Imma Aquino iD, Michele Peiretti iD, Alessandro Libretti iD

Journal of Clinical Medicine · 07.11.2026 · 15 (21) · 8690

DOI: 10.3390/jcm15218690 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.11.2026. Verfasst von Raffaele Tinelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, "Valle d'Itria" Hospital, 74015 Martina Franca, Italy. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sentinel lymph node (SLN) mapping is an established approach to nodal staging in presumed uterine-confined endometrial cancer, but its integration with molecular risk assessment raises unresolved clinical questions. This narrative review examines tracer and injection-site selection, persistent mapping failure, high-risk histologies, para-aortic assessment, low-volume nodal disease, and interpretation across POLEmut, MMRd, NSMP and p53abn tumors. A focused literature update and bibliographic verification were performed in October 2026. Cervical indocyanine green injection with near-infrared imaging supports reproducible pelvic mapping; comparative tracer studies favor it over blue dye. Prospective high-risk cohorts demonstrate high diagnostic accuracy when a complete algorithm is applied, but do not establish survival non-inferiority within every histologic or molecular subgroup. An unmapped hemipelvis requires technical reassessment and management according to baseline staging indication and operative feasibility. Negative pelvic SLNs do not exclude all para-aortic disease; additional assessment should address a defined treatment-planning question. Micrometastases constitute nodal metastasis, whereas isolated tumor cells are reported as pN0(i+). Molecularly annotated cohorts refine prognostic interpretation, but do not validate subgroup-specific treatment rules for low-volume disease. Future trials should evaluate treatment changes, morbidity and oncologic outcomes, rather than detection alone. The review distinguishes current staging practice from prognostic observations and hypotheses requiring prospective validation.

Schlagwörter

Stichwörter der Autor:innen

endometrial cancerfailed mappinghigh-risk histologyindocyanine greenmolecular classificationpara-aortic lymph nodessentinel lymph nodeultrastaging

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, "Valle d'Itria" Hospital, 74015 Martina Franca, Italy.
  • Department of Medical and Surgical Sciences, Institute of Obstetrics and Gynecology, University of Foggia, 71122 Foggia, Italy.
  • Department of Gynaecology and Obstetrics, University Hospital Maggiore Della Carità, Corso Mazzini, 18, 28100 Novara, Italy.
  • Department of Obstetrics and Gynecology, University Hospital "Degli Infermi", 13875 Ponderano, Italy.
  • Division of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.
  • Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.

ORCID-Profile: Raffaele Tinelli, Felice Sorrentino, Daniela Surico, Alessandro Messina, Giorgio Bogani, Carmen Imma Aquino, Michele Peiretti, Alessandro Libretti

Zitieren

APA

Tinelli, R., Sorrentino, F., Surico, D., Messina, A., Angioni, S., Bogani, G., Aquino, C. I., Peiretti, M., & Libretti, A. (2026). Sentinel Lymph Node Mapping in Endometrial Cancer in the Molecular Era: Current Evidence, Clinical Controversies, and Unresolved Questions. Journal of Clinical Medicine, 15(21), 8690. https://doi.org/10.3390/jcm15218690

Vancouver

Tinelli R, Sorrentino F, Surico D, Messina A, Angioni S, Bogani G, et al. Sentinel Lymph Node Mapping in Endometrial Cancer in the Molecular Era: Current Evidence, Clinical Controversies, and Unresolved Questions. Journal of Clinical Medicine. 2026;15(21):8690. doi:10.3390/jcm15218690

BibTeX
@article{Tinelli2026,
  author = {Tinelli, Raffaele and Sorrentino, Felice and Surico, Daniela and Messina, Alessandro and Angioni, Stefano and Bogani, Giorgio and Aquino, Carmen Imma and Peiretti, Michele and Libretti, Alessandro},
  title = {Sentinel Lymph Node Mapping in Endometrial Cancer in the Molecular Era: Current Evidence, Clinical Controversies, and Unresolved Questions},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8690},
  doi = {10.3390/jcm15218690}
}
Kostenlos starten →